Classifying Africans with the Metabolic Syndrome

Abstract

This study was aimed to compare prevalences of the metabolic syndrome in Africans using five definitions as proposed by the World Health Organization (WHO), the European Group for the Study of Insulin Resistance (EGIR), the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults [Adult Treatment Panel (ATPIII)], the American College of Endocrinology (ACE), and the International Diabetes Federation (IDF). A further objective was to identify difficulties in classifying Africans with the metabolic syndrome and to suggest specific areas where criteria adjustments for identifying Africans should be made. A case-case-control cross-sectional study involved 102 urban African women. Except for microalbumin data, all data necessary for classification of the metabolic syndrome were collected, including fasting and 2-h glucose and insulin, anthropometric measurements, blood pressure, and lipids. The metabolic syndrome prevalences ranged from 5.4% (EGIR), 15.7% (ATPIII), ≥19.4% (WHO), 24.8% (IDF) to 25.5% (ACE). Only 2.9% (n=3) had a triglyceride level ≥1.69 mmol/l, but 58.8% (n=60) had a HDL-level <1.29 mmol/l, whereas 27% (n=26) were insulin resistant, 22.3% (n=21), had a blood pressure ≥140/90 or used hypertension medication. It seems as if the classification of hypertension, insulin resistance and hyperglycemia might have been adequate, but body composition and dyslipidemia criteria need adjustment for Africans. Since neither definition seems completely suitable for Africans it is suggested that clinical emphasis should rather be on treating any specific cardiovascular disease risk factor that is present, than on diagnosing a patient with the metabolic syndrome.

Key words

ethnicity - waist circumference - insulin resistance - triglycerides - hypertension - diabetes

References

• 1 MacLaughlin TL, Reaven GM. Beyond type 2 diabetes: the need for a clinically useful way to identify insulin resistance.  Am J Med. 2003;  114 501-502
• 2 Ford ES, Giles WH. A comparison of the prevalence of the metabolic syndrome using two proposed definitions.  Diabetes Care. 2003;  26 575-581
• 3 World Health Organization .Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO Consultation. Part 1. Diagnosis and classification of diabetes melliltus. Geneva: World Health Organization 1999
• 4 The European Group for the study of Insulin Resistance (EGIR) . Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome.  Diabetes Metab. 2002;  28 364-376
• 5 Third Report of the National Cholesterol Education Program (NCEP) . Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.  Circulation. 2002;  106 3143-3421
• 6 American College of Endocrinology Position Statement, Insulin Resistance Syndrome. 2002; 
• 7 The IDF consensus worldwide definition of the metabolic syndrome. International Diabetes Federation 2005
• 8 Aguilar-Salinas CA, Rojas R, Gomez-Perez FJ, Valles V, Rios-Torres JM, Franco A, Olaiz G, Rull JA, Sepulveda J. Analysis of the agreement between the World Health Organization criteria and the National Cholesterol Education Program-III definition of the metabolic syndrome: results from a population-based survey.  Diabetes Care. 2003;  26 1635
• 9 Brown TM, Vaidya D, Rogers WJ, Waters DD, Howard BV, Tardif JC, Bittner V. Does prevalence of the metabolic syndrome in women with coronary artery disease differ by the ATP III and IDF criteria?.  J Womens Health (Larchmt). 2008;  17 841-847
• 10 Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR).  Diabet Med. 1999;  16 442-443
• 11 Reaven GM. The metabolic syndrome: is this diagnosis necessary?.  Am J Clin Nutr. 2006;  83 1237-1247
• 12 Pavkov ME, Hanson RL, Knowler WC, Bennett PH, Krakoff J, Nelson RG. Changing patterns of type 2 diabetes incidence among Pima Indians.  Diabetes Care. 2007;  30 1758-1763
• 13 Daniel M, Rowley KG, MacDermott R, O’Dea K. Diabetes and impaired glucose tolerance in Aboriginal Australians: prevalence and risk.  Diabetes Res Clin Pract. 2002;  57 23-33
• 14 Vorster HH, Bourne LT, Venter CS, Oosthuizen W. Contribution of nutrition to the health transition in developing countries: a framework for research and intervention.  Nutr Rev. 1999;  57 341-349
• 15 Vorster HH. The emergence of cardiovascular disease during urbanisation of Africans.  Public Health Nutr. 2002;  5 239-243
• 16 Onyegbutulem HC, H-Onyegbutulem PI, Reimann M, Li J, Bornstein SR, Schwarz PE. Metabolic syndrome in Africa: an emerging perspective.  Horm Metab Res. 2008;  , [in press]
• 17 UNAIDS . Sub-Saharan Africa. AIDS epidemic update. , Regional Summary 2008; 
• 18 Moyle GJ. Lipid abnormalities during ART: it's the drug, not the class.  AIDS Read. 2004;  14 15-16 , 20–22
• 19 Schutte AE, Kruger HS, Wissing MP, Underhay C, Vorster HH. The emergence of the metabolic syndrome in urban obese African women: The POWIRS-Study.  S Afr J Sci. 2005;  101 61-67
• 20 World Health Organization .Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation on Obesity, June 3–5. Geneva: World Health Organization 1997
• 21 Norton K, Olds T. Anthropometrica. A textbook of body measurement for sports and health courses. Sydney: University of New South Wales Press 1996
• 22 Imholz BPM, Wieling W, Montfrans GA van, Wesseling KH. Fifteen years experience with finger arterial pressure monitoring: assessment of the technology.  Cardiovasc Res. 1998;  38 605-616
• 23 Schutte AE, Huisman HW, Rooyen JM van, Malan NT, Schutte R. Validation of the Finometer device for measurement of blood pressure in black women.  J Hum Hypertens. 2004;  18 79-84
• 24 Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease.  Diabetes. 1988;  37 1595-1607
• 25 Schutte AE, Olckers A. Metabolic syndrome risk in black South African women compared to Caucasian women.  Horm Metab Res. 2007;  39 651-657
• 26 Phillips LK, Prins JB. The link between abdominal obesity and the metabolic syndrome.  Curr Hypertens Rep. 2008;  10 156-164
• 27 Lee S, Gungor N, Bacha F, Arslanian S. Insulin resistance: link to the components of the metabolic syndrome and biomarkers of endothelial dysfunction in youth.  Diabetes Care. 2007;  30 2091-2097
• 28 Levitt NS, Lambert EV, Woods D, Hales CN, Andrew R, Seckl JR. Impaired glucose tolerance and elevated blood pressure in low birth weight, nonobese, young south African adults: early programming of cortisol axis.  J Clin Endocrinol Metab. 2000;  85 4611-4618
• 29 Li C, Johnson MS, Goran MI. Effects of low birth weight on insulin resistance syndrome in caucasian and African-American children.  Diabetes Care. 2001;  24 2035-2042
• 30 Sobngwi E, Mauvais-Jarvis F, Vexiau P, Mbanya JC, Gautier JF. Diabetes in Africans. Part 1: epidemiology and clinical specificities.  Diabetes Metab. 2001;  27 628-634
• 31 Reimann M, Schutte AE, Schwarz PE. Insulin resistance – the role of ethnicity: evidence from Caucasian and African cohorts.  Horm Metab Res. 2007;  39 853-857
• 32 Rooyen JM, Pretorius PJ, Britz M, Huisman HW, Schutte AE, Towers GW, Olckers A, Schwarz PE, Malan NT, Malan L, Schutte R. Genetic polymorphisms of beta2- and beta3-adrenergic receptor genes associated with characteristics of the metabolic syndrome in black South African women.  Exp Clin Endocrinol Diabetes. 2008;  116 236-240
• 33 Walker AR, Walker BF, Walker AJ, Vorster HH. Low frequency of adverse sequelae of obesity in South African rural black women.  Int J Vitam Nutr Res. 1989;  59 224-228
• 34 Schutte AE, Huisman HW, Rooyen JM van, Schutte R, Malan L, Reimann M, Ridder JH de, van der MA, Schwarz PE, Malan NT. Should obesity be blamed for the high prevalence rates of hypertension in black South African women?.  J Hum Hypertens. 2008;  22 528-536
• 35 Harris MM, Stevens J, Thomas N, Schreiner P, Folsom AR. Associations of fat distribution and obesity with hypertension in a bi-ethnic population: the ARIC study. Atherosclerosis Risk in Communities Study.  Obes Res. 2000;  8 516-524
• 36 Kruger HS, Venter CS, Vorster HH. Obesity in African women in the North West Province, South Africa is associated with an increased risk of non-communicable diseases: the THUSA study.  Br J Nutr. 2001;  86 733-740
• 37 Opie LH, Seedat YK. Hypertension in sub-Saharan African populations.  Circulation. 2005;  112 3562-3568
• 38 Rooyen JM van, Kruger HS, Huisman HW, Wissing MP, Margetts BM, Venter CS, Vorster HH. An epidemiological study of hypertension and its determinants in a population in transition: the THUSA study.  J Hum Hypertens. 2000;  14 779-787
• 39 Rooyen JM van, Huisman HW, Eloff FC, Laubscher PJ, Malan L, Steyn HS, Malan NT. Cardiovascular reactivity in Black South-African males of different age groups: the influence of urbanization.  Ethn Dis. 2002;  12 69-75
• 40 Ergul A. Hypertension in black patients: an emerging role of the endothelin system in salt-sensitive hypertension.  Hypertension. 2000;  36 62-67
• 41 Mensah GA. Epidemiology of stroke and high blood pressure in Africa.  Heart. 2008;  94 697-705
• 42 Seedat YK. Hypertension in black South Africans.  J Hum Hypertens. 1999;  13 96-103
• 43 Oosthuizen W, Vorster HH, Kruger A, Venter CS, Kruger HS, Ridder JH de. Impact of urbanisation on serum lipid profiles–the THUSA survey.  S Afr Med J. 2002;  92 723-728
• 44 Motala AA, Esterhuizen T, Gouws E, Pirie FJ, Omar MA. Diabetes mellitus and other disorders of glycaemia in a rural South African community: prevalence and associated risk factors.  Diabetes Care. 2008;  31 1783-1788
• 45 Schwarz PE, Reimann M, Li J, Bergmann A, Licinio J, Wong ML, Bornstein SR. The Metabolic Syndrome – a global challenge for prevention.  Horm Metab Res. 2007;  39 777-780
• 46 Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.  Diabetes Care. 2005;  28 2289-2304

Correspondence